Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
Luke.jones@well.ox.ac.uk

Research groups

Carroll Group: High Consequence Emerging Viruses Group

Luke Jones

Postdoctoral researcher in the Carroll Group. Working on coronavirus and other emerging virus therapeutics, and neurovirulence studies of SARS-CoV-2.

Recent publications

Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2
Cornish K. et al, (2024), Open Biology, 14
Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials
Chan XHS. et al, (2024)
Antiviral mechanism change of poly(styrene sulfonate) through gold nanoparticle coating
Bhebhe LM. et al, (2024), Polymer Chemistry, 15, 945 - 951
Pathological features of African horse sickness virus infection in IFNAR−/− mice
Jones LM. et al, (2023), Frontiers in Veterinary Science, 10
Broad-Spectrum Extracellular Antiviral Properties of Cucurbit[n]urils
Jones LM. et al, (2022), ACS Infectious Diseases, 8, 2084 - 2095

More publications